Results 21 to 30 of about 120,548,321 (260)

Botulinum toxin in the treatment of pemphigus vegetans of the scalp [PDF]

open access: yesSurgical & Cosmetic Dermatology
Pemphigus vegetans is a rare clinical form of pemphigus vulgaris, and scalp involvement is even rarer. Treatment can be challenging, often requiring systemic immunosuppression.
André Pozzobon Capeletti   +3 more
doaj   +1 more source

Botulinum toxin type B micromechanosensor [PDF]

open access: yesProceedings of the National Academy of Sciences, 2003
Botulinum neurotoxin (BoNT) types A, B, E, and F are toxic to humans; early and rapid detection is essential for adequate medical treatment. Presently available tests for detection of BoNTs, although sensitive, require hours to days. We report a BoNT-B sensor whose properties allow detection of BoNT-B within minutes.
W, Liu   +4 more
openaire   +2 more sources

Preoperative botulinum toxin type A: A case report of a proposed new strategy for giant hiatal hernia management

open access: yesClinical Case Reports, 2020
The use of preoperative ventral botulinum toxin for giant hiatal hernia management.
Francisco Tustumi   +8 more
doaj   +1 more source

The Use of Botulinum Toxin in the Treatment of Headache: an Integrative Literature Review

open access: yesHeadache Medicine, 2023
Full abstract in PDF.
Stephanie Bezerra Muniz Falcão   +14 more
doaj   +2 more sources

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis

open access: yesFrontiers in Microbiology, 2022
Botulinum neurotoxin (BoNT) is one of the most dangerous bacterial toxins and a potential biological weapon component. BoNT mechanism of pathological action is based on inhibiting the release of neurotransmitters from nerve endings.
Artem A. Derkaev   +9 more
doaj   +1 more source

Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]

open access: yes, 2013
Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Fowler, CJ   +13 more
core   +1 more source

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome [PDF]

open access: yesInternational Neurourology Journal, 2015
Intravesical onabotulinumtoxinA (BoNT-A) injection is an effective treatment for overactive bladder syndrome (OAB) that is refractory to antimuscarinics.
Chun-Hou Liao, Hann-Chorng Kuo
doaj   +1 more source

Treating the face of women with botulinum toxin type A: 7-year review [PDF]

open access: yesRevista Brasileira de Cirurgia Plástica, 2023
Introduction: Botulinum toxin type A (BTX-A) is the number one aesthetic procedure worldwide, and the difficulty in standardizing the aesthetic treatment of the face results in a broad range of treatment possibilities.
Victor Hugo Lara Cardoso Sá   +3 more
doaj   +1 more source

Botulinum Neurotoxins (BoNTs) and Their Biological, Pharmacological, and Toxicological Issues: A Scoping Review

open access: yesApplied Sciences, 2021
Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini   +10 more
doaj   +1 more source

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials

open access: yesToxins, 2023
DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004).
Conor J. Gallagher   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy